Pyrimidine compounds and pyrimido indole compounds and methods of use
AssigneeDuquesne University of the Holy Spirit
InventorAleem Gangjee
Life of this patent
Estimating the term…
Abstract
The present invention discloses a compound comprising the formula: wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, or a compound of the formula wherein the S is replaced by CH2, and optionally comprising a pharmaceutically acceptable salt, hydrate, or solvate thereof. A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of the compound or pharmaceutically acceptable salt, hydrate, or solvate thereof.
Claims31
A compound comprising the formula:
- wherein R is selected from one of the following groups consisting of:
- and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
(canceled)
A compound comprising the formula:
- and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A compound comprising the formula:
- wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A compound comprising the formula:
- wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A compound comprising the formula:
- wherein R1 is hydrogen or an alkyl group having from one to ten carbon atoms, R2 is hydrogen or an alkyl group having from one to ten carbon atoms, R3 is hydrogen or an alkyl group having from one to ten carbon atoms, and R4 is hydrogen or an alkyl group having from one to ten carbon atoms, wherein R1, R2, R3, and R4 are independently selected and may be the same or different, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A compound comprising the formula:
- wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A compound comprising the formula:
- wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A compound comprising the formula:
- and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
(canceled)
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- wherein R is selected from one of the following groups consisting of:
- and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
(canceled)
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- wherein R1 is hydrogen or an alkyl group having from one to ten carbon atoms, R2 is hydrogen or an alkyl group having from one to ten carbon atoms, R3 is hydrogen or an alkyl group having from one to ten carbon atoms, and R4 is hydrogen or an alkyl group having from one to ten carbon atoms, wherein R1, R2, R3, and R4 are independently selected and may be the same or different, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula:
- and optionally comprising a pharmaceutically acceptable salt or hydrate thereof.
(canceled)
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- wherein R is selected from one of the following groups consisting of:
- and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- wherein R is 2-OCH3, 3-OCH3, 4-OCH3, or 3,4-diOCH3, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- wherein R1 is hydrogen or an alkyl group having from one to ten carbon atoms, R2 is hydrogen or an alkyl group having from one to ten carbon atoms, R3 is hydrogen or an alkyl group having from one to ten carbon atoms, and R4 is hydrogen or an alkyl group having from one to ten carbon atoms, wherein R1, R2, R3, and R4 are independently selected and may be the same or different, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- wherein R is hydrogen or an alkyl group having from one to ten carbon atoms, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
A method of treating a patient having cancer or a disease comprising administering to a patient an effective amount of a compound comprising formula:
- wherein R is hydrogen, an alkyl group having from one to ten carbon atoms, NH2, I, or CN, and optionally comprising a pharmaceutically acceptable salt or hydrate or solvate thereof, and including administering an effective amount of said salt, hydrate, or solvate of said compound to said patient.
(canceled)
Dependencies are inferred from the claim text.